Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
hcven.com

See what CB Insights has to offer

Investments

31

Portfolio Exits

11

Funds

9

Service Providers

1

About HealthCare Ventures

HealthCare Ventures is a life science venture capital firm investing in pre-clinical or early clinical stage, project-focused companies with potential to transform patient care. They aim to identify high potential products within academia or pharmaceutical companies, develop them to clinical proof-of-concept within capital efficient, semi-virtual organizations, and generate superior returns through acquisitions by pharmaceutical and biotechnology companies.

HealthCare Ventures Headquarter Location

47 Thorndike St B1

Cambridge, Massachusetts, 02141,

United States

617-252-4343

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

HealthCare Ventures Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

HealthCare Ventures Rank

Latest HealthCare Ventures News

Short Position - Planters’ bane, Healthcare ventures,

Jul 15, 2022

Saturday, 16 Jul 2022 For decades, Indonesia has been the mecca for many Malaysian plantation companies as a reliable source for migrant estate workers.However, this is no longer the case, especially when Indonesia took over the status of the world’s largest producer of palm oil from Malaysia with many Indonesians opted to stay home and work in the oil palm estates there. Planters’ bane IT was a rude awakening for local planters this week, when Indonesia again displayed its inconsistent policy by freezing the recruitment of its workers for Malaysia. Hopes were dashed for the arrival of the first batch of 32,000 Indonesian workforce meant for the sector here. For decades, Indonesia has been the mecca for many Malaysian plantation companies as a reliable source for migrant estate workers. However, this is no longer the case, especially when Indonesia took over the status of the world’s largest producer of palm oil from Malaysia with many Indonesians opted to stay home and work in the oil palm estates there. Ironically, some of the big oil palm plantations in the republic are also owned by several high-profile Malaysian planters. With the Covid-19 pandemic, the shortage situation in the local plantation scene has escalated further to 120,000 workers currently from about 60,000 workers during the pre-pandemic period. Of the 2.06 million legally-registered foreign workers in Malaysia, the labour-intensive plantation sector hired about 268,203 or about 15.9%, alongside with other sectors such as construction, manufacturing, agricultural and domestic maids. With Indonesia’s latest temporary freeze on its workers for Malaysia, the best bet would be for local planters to seek elsewhere, perhaps from India and Pakistan as suggested by the Plantation Industries and Commodities Minister Datuk Zuraida Kamaruddin. Another alternative is to bump up on the mechanisation and automation in the oil palm estates – an idea which often looks good on paper but still has yet to take off on a successful route. Another suggestion is for the government to provide a higher matching grant from the current RM30mil for investment in the mechanisation and automation in the estate operations. This perhaps could further encourage planters to take on the automation programme on a more serious note. Apparently, the freeze of Indonesian workers to Malaysia also coincides with the upcoming palm oil peak production months. The Malaysian Estate Owners Association reveals that any potential delay in harvesting the fresh fruit bunches may result in its members suffering 5% to 10% losses in earnings due to the current severe labour crunch. Healthcare ventures SUCCESSFUL healthcare providers tend to get ascribed with high valuations. Listed medical groups in Malaysia are a good example. are good examples of having price-earning ratios of more than 30 times. Newcomer Cengild Medical Bhd managed to secure an earnings multiple of 27 times when it was floated earlier this year. The reasons why these companies enjoy a high earnings multiple is because of the high entry barrier to the business. Medical equipment costs a lot and there are other high operational costs too. It also requires a fair bit of expertise and medical personnel who are able to win the trust of the customers. This is why healthcare ventures take a while before they start showing profits let alone sustainable profit margins. During the Covid-19 pandemic, a number of listed companies sought to venture into the healthcare business by announcing businesses related to vaccine distribution or even production. None of the companies have managed to eke out solid profits from those ventures. More stable plans have come from companies such as LYC Healthcare Bhd, which first ventured into healthcare back in 2018 by focusing on a niche. It opened its first mother and child centre that year. The company has made other inroads into the healthcare space, which could prove to be profitable in the future. But for now, it is still remains loss making, indicating the long gestation period for these businesses plus the impact that the pandemic has likely had on it. This week, another loss-making company, Omesti Bhd , said it has formed a joint venture to set up and operate diagnostic and screening centres. Omesti has said that it plans to increase its investment in the healthcare services segment. Payback, though, may not be that fast or lucrative. Article type: free

HealthCare Ventures Investments

31 Investments

HealthCare Ventures has made 31 investments. Their latest investment was in MyOme as part of their Series B on June 6, 2022.

CBI Logo

HealthCare Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

6/21/2022

Series B

MyOme

$23M

Yes

2

7/13/2020

Series B - III

Paige

$20M

Yes

8

9/12/2011

Series A

Tensha Therapeutics

$15M

Yes

3

8/2/2011

Series A

Subscribe to see more

$99M

Subscribe to see more

10

1/7/2011

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

6/21/2022

7/13/2020

9/12/2011

8/2/2011

1/7/2011

Round

Series B

Series B - III

Series A

Series A

Series A

Company

MyOme

Paige

Tensha Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$23M

$20M

$15M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

2

8

3

10

10

HealthCare Ventures Portfolio Exits

11 Portfolio Exits

HealthCare Ventures has 11 portfolio exits. Their latest portfolio exit was Tensha Therapeutics on January 11, 2016.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

1/11/2016

Acquired

$99M

3

2/7/2008

Acquired

$99M

Undisclosed Investors

9/15/2001

Acquired

$99M

9/8/2000

Acquired

Subscribe to see more

$99M

Subscribe to see more

0

8/3/2000

IPO

Subscribe to see more

$99M

Subscribe to see more

0

Date

1/11/2016

2/7/2008

9/15/2001

9/8/2000

8/3/2000

Exit

Acquired

Acquired

Acquired

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Undisclosed Investors

Subscribe to see more

Subscribe to see more

Sources

3

0

0

HealthCare Ventures Fund History

9 Fund Histories

HealthCare Ventures has 9 funds, including HealthCare Ventures VIII LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

8/18/2005

HealthCare Ventures VIII LP

Early-Stage Venture Capital

Closed

$379M

1

11/19/2002

HealthCare Ventures VII LP

Subscribe to see more

Subscribe to see more

$99M

10

12/21/2000

HealthCare Ventures VI LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1997

HealthCare Ventures V LP

Subscribe to see more

Subscribe to see more

$99M

10

4/30/1993

HealthCare Ventures III & IV LP

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

8/18/2005

11/19/2002

12/21/2000

12/31/1997

4/30/1993

Fund

HealthCare Ventures VIII LP

HealthCare Ventures VII LP

HealthCare Ventures VI LP

HealthCare Ventures V LP

HealthCare Ventures III & IV LP

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$379M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

HealthCare Ventures Service Providers

1 Service Provider

HealthCare Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

HealthCare Ventures Team

7 Team Members

HealthCare Ventures has 7 team members, including current Managing Director, Douglas E. Onsi.

Name

Work History

Title

Status

Douglas E. Onsi

Managing Director

Current

Harold R. Werner

Managing Director

Current

Mads Emil Matthiesen

Owner

Current

Fiona Marston

Absynth Biologics, H2O Venture Partners, Novacta Biosystems, Metris Therapeutics, and Celltech

Chief Executive Officer

Former

James Kuo

Managing Director

Former

Name

Douglas E. Onsi

Harold R. Werner

Mads Emil Matthiesen

Fiona Marston

James Kuo

Work History

Absynth Biologics, H2O Venture Partners, Novacta Biosystems, Metris Therapeutics, and Celltech

Title

Managing Director

Managing Director

Owner

Chief Executive Officer

Managing Director

Status

Current

Current

Current

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.